INVESTORS

canaan partnersCanaan Partners

Canaan Partners invests in entrepreneurs and works alongside them to turn visionary ideas into valuable companies.  Since 1987, the firm has catalyzed the growth of disruptive technology startups and healthcare companies revolutionizing the practice of medicine.  With $3.4 billion under management and more than 95 acquisitions and 55 IPOs to date, Canaan has funded healthcare companies such as Advanced BioHealing (acquired by Shire); Advance PCS (acquired by Caremark), BiPar Sciences (acquired by Sanofi); Calixa Therapeutics (acquired by Cubist); Cerexa Pharmaceuticals (acquired by Forest Labs); Chimerix (NASDAQ: CMRX); Durata Therapeutics (NASDAQ: DRTX); Elevation Pharmaceuticals (acquired by Sunovion) and Peninsula Pharmaceuticals (acquired by Johnson & Johnson).The Canaan healthcare portfolio includes emerging leaders such as Liquidia Technologies, Civitas Therapeutics and DICOM Grid. Canaan maintains a presence in the global innovation hubs of New York, Silicon Valley, India and Israel.

www.canaan.com

morningsideMorningside Group

Morningside Group was founded in 1986, by the Chan family of Hong Kong, to make private equity and venture capital investments.  The group is managed by investment professionals who are entrepreneurial, have deep industry knowledge and are effective in the local environment in which they operate. In addition to its investment activities, Morningside Group is strongly committed to social responsibility.


www.morningside.com

neaNew Enterprise Associates

New Enterprise Associates, Inc. (NEA) is a leading venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With more than $14 billion in committed capital, NEA invests in information technology, healthcare and energy technology companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm’s long track record of successful investing includes more than 170 portfolio company IPOs and more than 300 acquisitions. In the U.S., NEA has offices in the Washington, D.C. metropolitan area; Menlo Park, California; and New York City. In addition, New Enterprise Associates (India) Pvt. Ltd. has offices in Bangalore and Mumbai, India and New Enterprise Associates (Beijing), Ltd. has offices in Beijing and Shanghai, China.

www.nea.com

pappasPappas Ventures

Founded in 1994, Pappas Ventures invests exclusively in the life sciences sector – biotechnology,biopharmaceuticals, drug delivery, medical devices and related ventures. Pappas Ventures has more than $350 million in capital under management, and has guided the launch and/or development of more than 50 life sciences companies, including Arena Pharmaceuticals (Nasdaq:ARNA), Plexxikon (acquired by Daiichi Sankyo), Cerexa (acquired by Forest Laboratories), Peninsula Pharmaceuticals (acquired by Johnson & Johnson), NuVasive (Nasdaq: NUVA), TESARO (Nasdaq: TSRO), and Chimerix (Nasdaq: CMRX). Pappas Ventures is based in Research Triangle Park, NC.

www.pappasventures.com

wakefieldWakefield Group

Wakefield Group is a venture capital firm focused on providing growth capital to growing businesses. The firm focuses its investments in technology, health, and business services and media. Within healthcare the firm focuses on software, devices, and human-genome technologies. Wakefield Group was founded in 1988 and has offices in Charlotte and Chapel Hill, North Carolina.

 

Copyright 2013 Envisia Therapeutics